Histocompatability

Or you can go back to the Test Main Page.

Asymptomatic screening and genome sequencing help Cambridge understand spread of SARS-CoV-2 among its students January 11, 2021
Initial results suggest that the screening programme, together with the University’s public health measures and responsible student behaviour, has helped limit the spread of the virus. Now, the team running the programme has joined up with researchers at the COVID-19 Genomics UK Consortium (COG-UK) to track how infections spread among the student population. They have shown how […]
Cambridge-led SARS-CoV-2 genomic surveillance consortium receives £12.2 million November 16, 2020
The additional investment will enable COG-UK to grow and strengthen current genomic surveillance efforts spearheaded by the Wellcome Sanger Institute and the University of Cambridge, together with the four UK Public Health Agencies and other COG-UK partners, with the aim of increasing sequencing capacity across the national network and reducing turnaround time from patient sample […]
Drug-resistant hospital bacteria persist even after deep cleaning, genomic study reveals October 26, 2020
Enterococcus faecium is a bacterium commonly found in the gastrointestinal tract, where it usually resides without causing the host problems. However, in immunocompromised patients, it can lead to potentially life-threatening infection. Over the last three decades, strains have emerged that are resistant to frontline antibiotics including ampicillin and vancomycin, limiting treatment options – and particularly […]

Histocompatability

East of England NHS Genomic Medicine Centre